Clinical Study to assess the efficacy and safety of fixed dose combination of S-Metoprolol, Atorvastatin and Ramipril tablets in hypertension coexisting with hyperlipidemia

Trial Profile

Clinical Study to assess the efficacy and safety of fixed dose combination of S-Metoprolol, Atorvastatin and Ramipril tablets in hypertension coexisting with hyperlipidemia

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Atorvastatin/S-metoprolol/ramipril (Primary)
  • Indications Essential hypertension; Hyperlipidaemia
  • Focus Therapeutic Use
  • Sponsors Emcure Pharmaceuticals
  • Most Recent Events

    • 01 Mar 2012 Planned End Date changed to 1 Jul 2012.
    • 01 Mar 2012 Status changed from completed to active, no longer recruiting.
    • 16 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top